The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...

Any time we try a healthy new way of eating, it’s easy for doubt to creep in. Is it really working? Is it worth it? Does it ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...

DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...

A recently published study highlighted the strong performance of the Insulet (Nasdaq:PODD) Omnipod 5 in children and young ...

Sitting before senators at his confirmation hearing to become commissioner of the FDA, Johns Hopkins surgeon and author ...

Almost 2.4 million Americans wear continuous glucose monitors, or CGMs, to track their blood sugar—and not all of them have ...

Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.

For thousands of people across the country, access to the Dexcom G7 sensor is strained because of ... to do because we see that if they have that CGM on, it’s more reliable,” said Dr.

You can view the full video interview above or read the Q&A transcript below. Polsky: A CGM is a small sensor that is inserted into the skin that measures the interstitial glucose value ...